JPRN-UMIN000010691已完成1 期
A Randomized PhaseI/ II study of HSP70mRNA transfected Dendritic Cells for the the Adjuvant immunotherapy of Hepatocellular carcinoma - H7DCAH study
Digestive Surgey and Surgical Oncology,Yamaguchi University Graduate School of Medicibe0 个研究点目标入组 45 人开始时间: 2013年5月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Without underlying diseases and allergy
研究者
相似试验
已完成
2 期
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital HerpesHerpes Simplex Type 2NCT01687595Agenus Inc.80
已完成
1 期
Phase I study of a gene modified, B7/IL-7-transfected allogeneic tumor cell vaccine for the treatment of metastatic renal cell carcinomaC64Malignant neoplasm of kidney, except renal pelvisDRKS00000294Medizinische Klinik für Hämatologie, Onkologie Charité, Campus Virchow10
已完成
不适用
SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)-C851 B-cell lymphoma, unspecified-C911 Chronic lymphocytic leukaemia of B-cell typeB-cell lymphoma, unspecifiedChronic lymphocytic leukaemia of B-cell typeC851C911PER-048-08SCHERING PLOUGH DEL PERU S.A.,2
已完成
不适用
A Randomized Phase 2 Study of SCH 727965 in Subjects With Advanced Breast and Non Small Cell Lung (NSCLC) CancersPER-002-10SCHERING PLOUGH RESEARCH INSTITUTE,
未知
1 期
A randomized, double-blind, placebo-controlled, continuous IV infusion for 96 hours, ascending dose study to assess the safety, pharmacokinetics and pharmacodynamics of CS-4771 in Japanese healthy subjectsHealthy male volunteersJPRN-jRCT2080221894DAIICHISANKYO Co.,Ltd.24